DuP 105

CAS No. 96800-41-8

DuP 105 ( —— )

Catalog No. M26183 CAS No. 96800-41-8

DuP 105 is an orally active oxazolidinone, a new class of synthetic antimicrobial agent with activity against gram-positive bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1791 Get Quote
10MG 2412 Get Quote
25MG 3582 Get Quote
50MG 4842 Get Quote
100MG 6534 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DuP 105
  • Note
    Research use only, not for human use.
  • Brief Description
    DuP 105 is an orally active oxazolidinone, a new class of synthetic antimicrobial agent with activity against gram-positive bacteria.
  • Description
    DuP 105 is an orally active oxazolidinone, a new class of synthetic antimicrobial agent with activity against gram-positive bacteria.(In Vitro):DuP 105 MICs for 50% of the 216 gram-positive isolates tested (MIC50s) range from 4.0 to 16 μg/mL.DuP 105 shows inhibitory activities against staphylococcal isolates and B. fragilis isolates with MIC90s of 4 to 16 μg/mL and 16 μg/mL.(In Vivo):DuP 105 administered by either the oral or the parenteral route is protective against staphylococcal and streptococcal infections in mice with the 50% effective doses of 9 to 23 mg/kg.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    96800-41-8
  • Formula Weight
    296.3
  • Molecular Formula
    C13H16N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)S(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nanda JS, Lorsch JR. Labeling a protein with fluorophores using NHS ester derivitization. Methods Enzymol. 2014;536:87-94.
molnova catalog
related products
  • Curculigoside

    Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.

  • Roniacol

    3-Pyridinemethanol is a useful synthetic intermediate.

  • Perflexane

    Perflexane was developed as an ultrasound contrast agent.